Clearside Historical Income Statement
| CLSD Stock | USD 1.08 0.06 5.88% |
Historical analysis of Clearside Biomedical income statement accounts such as Interest Expense of 9.8 M, Other Operating Expenses of 35.5 M or Research Development of 24.9 M can show how well Clearside Biomedical performed in making a profits. Evaluating Clearside Biomedical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Clearside Biomedical's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Clearside Biomedical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Clearside Biomedical is a good buy for the upcoming year.
Clearside |
About Clearside Income Statement Analysis
Clearside Biomedical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Clearside Biomedical shareholders. The income statement also shows Clearside investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Clearside Biomedical Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Clearside Biomedical. It is also known as Clearside Biomedical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Clearside Biomedical financial statement analysis. It represents the amount of money remaining after all of Clearside Biomedical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Clearside Biomedical minus its cost of goods sold. It is profit before Clearside Biomedical operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Most accounts from Clearside Biomedical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Clearside Biomedical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clearside Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For information on how to trade Clearside Stock refer to our How to Trade Clearside Stock guide.At present, Clearside Biomedical's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Other Operating Expenses is expected to grow to about 35.5 M, whereas EBIT is forecasted to decline to (24.3 M).
Clearside Biomedical income statement Correlations
Click cells to compare fundamentals
Clearside Biomedical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Clearside Biomedical income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 211K | 180K | 178K | 145K | 67K | 132.5K | |
| Interest Expense | 1.0M | 335K | 1.0M | 3.3M | 9.4M | 9.8M | |
| Other Operating Expenses | 32.5M | 25.8M | 30.2M | 31.6M | 33.1M | 35.5M | |
| Operating Income | (30.3M) | (17.9M) | (627K) | (30.3M) | (24.8M) | (26.1M) | |
| Ebit | (30.3M) | (17.9M) | (627K) | (29.6M) | (23.1M) | (24.3M) | |
| Research Development | 15.7M | 15.1M | 18.5M | 19.6M | 20.8M | 24.9M | |
| Ebitda | (30.1M) | (17.8M) | (449K) | (29.5M) | (23.1M) | (24.2M) | |
| Total Operating Expenses | 32.5M | 25.8M | 30.2M | 31.4M | 32.7M | 35.4M | |
| Income Before Tax | (30.8M) | (18.2M) | 376K | (32.9M) | (32.5M) | (34.1M) | |
| Total Other Income Expense Net | (466K) | (275K) | 1.0M | (2.7M) | (7.6M) | (7.3M) | |
| Net Income | (30.6M) | (18.0M) | 376K | (34.1M) | (32.5M) | (34.1M) | |
| Income Tax Expense | (211K) | (180K) | (58.6K) | 1.1M | (100.9K) | (95.9K) | |
| Selling General Administrative | 16.8M | 10.8M | 11.7M | 11.8M | 11.9M | 12.1M | |
| Total Revenue | 2.2M | 7.9M | 29.6M | 1.3M | 8.2M | 5.5M | |
| Gross Profit | 2.2M | 7.9M | 29.4M | 1.1M | 7.9M | 5.4M | |
| Net Income From Continuing Ops | (30.8M) | (18.2M) | 376K | (29.6M) | (32.5M) | (34.1M) | |
| Net Income Applicable To Common Shares | (30.8M) | (18.2M) | 376K | (32.9M) | (37.9M) | (39.8M) | |
| Non Operating Income Net Other | (466K) | (275K) | 1.0M | 669K | 769.4K | 807.8K | |
| Reconciled Depreciation | 211K | 180K | 178K | 145K | 67K | 131.7K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Clearside Biomedical is a strong investment it is important to analyze Clearside Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Clearside Biomedical's future performance. For an informed investment choice regarding Clearside Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clearside Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For information on how to trade Clearside Stock refer to our How to Trade Clearside Stock guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clearside Biomedical. If investors know Clearside will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clearside Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.45) | Revenue Per Share 0.112 | Quarterly Revenue Growth (0.91) | Return On Assets (0.44) | Return On Equity (13.10) |
The market value of Clearside Biomedical is measured differently than its book value, which is the value of Clearside that is recorded on the company's balance sheet. Investors also form their own opinion of Clearside Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Clearside Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clearside Biomedical's market value can be influenced by many factors that don't directly affect Clearside Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clearside Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clearside Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clearside Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.